Health Condition 1: L089- Local infection of the skin and subcutaneous tissue, unspecified
Conditions
Interventions
Intervention1: EpiFAst: SCFAs- Sodium acetate, sodium butyrate, and sodium propionate with complex carbohydrate Cellulose mixture will be used to wound dressing
Control Intervention1: Normal Saline: R
Sponsors
Intramural Research Grant AIIMS Bhubaneswar
Eligibility
Inclusion criteria
Inclusion criteria: Subjects with chronic ulcer for greater than 4 weeks. Any diabetic foot ulcer Willing and able to provide written informed consent
Exclusion criteria
Exclusion criteria: Subjects who are hypersensitive to complex carbohydrates contents A spreading ulcer in the last 2 weeks before presentation Female subjects who are nursing, pregnant, or planning on becoming pregnant during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. EpiFAst will reduce the time of wound healing. 2. EpiFAst will reduce debridement incidence. 3. EpiFAstwill reduce the incidence of infection. 4. EpiFAstwillimprove the quality of life of chronic lower extremity wounds. Timepoint: Before treatment samples (Baseline) and post-treatment sample (15th day) | — |
Secondary
| Measure | Time frame |
|---|---|
| EpiFAst will promote the beneficial microbiome on wound healingTimepoint: Before treatment samples (Baseline) and post-treatment sample (15th day) | — |
Countries
India
Contacts
Public ContactDr Sanjay Giri
AIIMS, Bhubaneswar
Outcome results
None listed